Prelude Capital Management, LLC Global Blood Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $4.05 Million - $8.52 Million	125,029 New	125,029 $8.51 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $290,093 - $491,347	-7,705 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $97,869 - $138,178	1,855 Added 31.71%	7,705 $425,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $285,070 - $478,646	5,850 New	5,850 $369,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $5,757 - $12,033	-138 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $685 - $1,227	15 Added 12.2%	138 $11,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $817,796 - $1.04 Million	-18,033 Reduced 99.32%	123 $6,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $405,440 - $487,839	7,708 Added 73.77%	18,156 $955,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $417,815 - $558,759	10,448 New	10,448 $553,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $1.81 Million - $2.68 Million	-57,446 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $314,754 - $423,261	8,283 Added 16.85%	57,446 $2.18 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $804,340 - $1.04 Million	20,784 Added 73.24%	49,163 $2.22 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $1.04 Million - $1.73 Million	26,183 Added 1192.3%	28,379 $1.37 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $160,290 - $246,642	-5,397 Reduced 71.08%	2,196 $86,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $190,584 - $235,762	7,593	7,593 $236,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.